Paper27490482
MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs.
Wood CD and 8 others. Elife, 2016. Cited by 86 papers, by iCite.
Cite this record
ConductScience Library. MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs. Papers, record 27490482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27490482
- Cell line
- GM1287849 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Cell lines1
Source Cell lines
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bcl-2-Like Protein 11 | Major topic |
| Epstein-Barr Virus Nuclear Antigens | Major topic |
| Gene Silencing | Major topic |
| Herpesvirus 4, Human | Major topic |
| Proto-Oncogene Proteins c-myc | Major topic |
| Transcriptional Activation | Major topic |
| DNA Helicases | |
| Nuclear Proteins | |
| Promoter Regions, Genetic | |
| Protein Binding | |
| Repressor Proteins | |
| Trans-Activators | |
| Transcription Factors |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MR/J002046/1 | Medical Research Council | United Kingdom | PubMed | |
| MR/K01952X/1 | Medical Research Council | United Kingdom | PubMed | |
| MR/N023781/1 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References79
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8709224 | Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1. | J Virol | 1996 | https://conductscience.org/library/papers/8709224 | PubMed |
| 2 | 23770605 | Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. | Nat Genet | 2013 | https://conductscience.org/library/papers/23770605 | PubMed |
| 3 | 19561604 | The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. | Nat Genet | 2009 | https://conductscience.org/library/papers/19561604 | PubMed |
| 4 | 1313908 | Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro. | J Virol | 1992 | https://conductscience.org/library/papers/1313908 | PubMed |
| 5 | 18758461 | A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. | Nat Genet | 2008 | https://conductscience.org/library/papers/18758461 | PubMed |
| 6 | 16314842 | EBV EBNA 2 stimulates CDK9-dependent transcription and RNA polymerase II phosphorylation on serine 5. | Oncogene | 2006 | https://conductscience.org/library/papers/16314842 | PubMed |
| 7 | 26428371 | EBNA2 and Its Coactivator EBNA-LP. | Curr Top Microbiol Immunol | 2015 | https://conductscience.org/library/papers/26428371 | PubMed |
| 8 | 26883634 | RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growth. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/26883634 | PubMed |
| 9 | 20548956 | Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP. | PLoS Pathog | 2010 | https://conductscience.org/library/papers/20548956 | PubMed |
| 10 | 25614448 | Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma. | Clin Cancer Res | 2015 | https://conductscience.org/library/papers/25614448 | PubMed |
| 11 | 18329371 | Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. | Cell | 2008 | https://conductscience.org/library/papers/18329371 | PubMed |
| 12 | 21085583 | Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification. | PLoS One | 2010 | https://conductscience.org/library/papers/21085583 | PubMed |
| 13 | 17541401 | Identification of two distinct MYC breakpoint clusters and their association with various IGH breakpoint regions in the t(8;14) translocations in sporadic Burkitt-lymphoma. | Leukemia | 2007 | https://conductscience.org/library/papers/17541401 | PubMed |
| 14 | 22903059 | Analysis of long-range chromatin interactions using Chromosome Conformation Capture. | Methods | 2012 | https://conductscience.org/library/papers/22903059 | PubMed |
| 15 | 25194570 | A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia. | Nat Med | 2014 | https://conductscience.org/library/papers/25194570 | PubMed |
| 16 | 8709211 | Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA. | J Virol | 1996 | https://conductscience.org/library/papers/8709211 | PubMed |
| 17 | 3097550 | The t(8; 14) chromosomal translocation occurring in B-cell malignancies results from mistakes in V-D-J joining. | Nature | 1986 | https://conductscience.org/library/papers/3097550 | PubMed |
| 18 | 20453196 | 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20453196 | PubMed |
| 19 | 3458257 | Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. | Proc Natl Acad Sci U S A | 1986 | https://conductscience.org/library/papers/3458257 | PubMed |
| 20 | 19767754 | Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. | Nat Genet | 2009 | https://conductscience.org/library/papers/19767754 | PubMed |
Cited by72
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 86 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42524018 | The role of Epstein-Barr virus in NK/T cell lymphoproliferative disorders: molecular mechanisms and potential therapeutic strategies. | Front Immunol | 2026 | https://conductscience.org/library/papers/42524018 | PubMed |
| 42509253 | Systematic profiling of AGO2-associated circRNAs and functional investigation reveal circN4BP2L2 as a survival-promoting regulator in T-ALL. | Leukemia | 2026 | https://conductscience.org/library/papers/42509253 | PubMed |
| 42277819 | Activation of c-Myc confers resistance to venetoclax via inhibition of Bim in t(8;21)-positive acute myeloid leukemia. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42277819 | PubMed |
| 40598900 | EBNA leader protein orchestrates chromatin architecture remodeling during Epstein-Barr virus-induced B cell transformation. | Nucleic Acids Res | 2025 | https://conductscience.org/library/papers/40598900 | PubMed |
| 40349096 | Molecular mechanisms of viral oncogenesis in haematological malignancies: perspectives from metabolic reprogramming, epigenetic regulation and immune microenvironment remodeling. | Exp Hematol Oncol | 2025 | https://conductscience.org/library/papers/40349096 | PubMed |
| 39869645 | Repression of CADM1 transcription by HPV type 18 is mediated by three-dimensional rearrangement of promoter-enhancer interactions. | PLoS Pathog | 2025 | https://conductscience.org/library/papers/39869645 | PubMed |
| 39817754 | Multiple sclerosis and infection: history, EBV, and the search for mechanism. | Microbiol Mol Biol Rev | 2025 | https://conductscience.org/library/papers/39817754 | PubMed |
| 39599857 | How Epstein Barr Virus Causes Lymphomas. | Viruses | 2024 | https://conductscience.org/library/papers/39599857 | PubMed |
| 38416644 | Enhancer-promoter activation by the Kaposi sarcoma-associated herpesvirus episome maintenance protein LANA. | Cell Rep | 2024 | https://conductscience.org/library/papers/38416644 | PubMed |
| 38390898 | Targeting SWI/SNF Complexes in Cancer: Pharmacological Approaches and Implications. | Epigenomes | 2024 | https://conductscience.org/library/papers/38390898 | PubMed |
| 37988227 | Epstein-Barr virus and host cell 3D genome organization. | J Med Virol | 2023 | https://conductscience.org/library/papers/37988227 | PubMed |
| 37324578 | Tumor hijacks macrophages and microbiota through extracellular vesicles. | Exploration (Beijing) | 2022 | https://conductscience.org/library/papers/37324578 | PubMed |
| 37112815 | Epstein-Barr Virus B Cell Growth Transformation: The Nuclear Events. | Viruses | 2023 | https://conductscience.org/library/papers/37112815 | PubMed |
| 36992423 | Epstein-Barr Virus History and Pathogenesis. | Viruses | 2023 | https://conductscience.org/library/papers/36992423 | PubMed |
| 36949074 | A DNA tumor virus globally reprograms host 3D genome architecture to achieve immortal growth. | Nat Commun | 2023 | https://conductscience.org/library/papers/36949074 | PubMed |
| 36945113 | A gain-of-function mutation in microRNA 142 is sufficient to cause the development of T-cell leukemia in mice. | Cancer Sci | 2023 | https://conductscience.org/library/papers/36945113 | PubMed |
| 36591236 | Impact of mature tertiary lymphoid structures on prognosis and therapeutic response of Epstein-Barr virus-associated gastric cancer patients. | Front Immunol | 2022 | https://conductscience.org/library/papers/36591236 | PubMed |
| 36398441 | Dynamics of Viral and Host 3D Genome Structure upon Infection. | J Microbiol Biotechnol | 2022 | https://conductscience.org/library/papers/36398441 | PubMed |
| 36389670 | EBV-associated diseases: Current therapeutics and emerging technologies. | Front Immunol | 2022 | https://conductscience.org/library/papers/36389670 | PubMed |
| 36383217 | Regulation of B cell receptor signalling by Epstein-Barr virus nuclear antigens. | Biochem J | 2022 | https://conductscience.org/library/papers/36383217 | PubMed |
Genes35
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/27490482
GET https://conductscience.org/api/papers/v1/27490482/references?page=2